# Study of the Safety & Efficacy of Leukine® in the Treatment of Alzheimer's Disease

> **NCT01409915** · PHASE2 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 44 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** Sagramostim
- **DRUG:** Saline -- placebo comparator

## Key facts

- **NCT ID:** NCT01409915
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2019-12-09
- **Final completion:** 2019-12-09
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2021-06-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01409915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01409915, "Study of the Safety & Efficacy of Leukine® in the Treatment of Alzheimer's Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01409915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*